Clinical Study

Renal Transplantation Dramatically Reduces IgA Anti-beta-2-glycoprotein I Antibodies in Patients with Endstage Renal Disease

Figure 6

Evolution of aPL antibodies in posttransplant serum samples grouped in time periods. (a) Anti-cardiolipin IgG (white). IgM (dark) and IgA (gray) isotypes. (b) aB2GPI antibodies IgG (White) and IgM (dark). Cut-off is shown with a dotted line.
641962.fig.006a
(a)
641962.fig.006b
(b)